- Home
- CMP vs PSNL Comparison
CMP vs PSNL Comparison
Compare CMP & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMP | PSNL |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.2M | 746.8M |
| IPO Year | 2003 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CMP | PSNL |
|---|---|---|
| Price | $19.53 | $7.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $20.25 | $10.71 |
| AVG Volume (30 Days) | 680.9K | ★ 1.4M |
| Earning Date | 02-09-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,243,900,000.00 | $69,103,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.28 | $20.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.32 | N/A |
| 52 Week Low | $8.60 | $2.83 |
| 52 Week High | $22.69 | $11.40 |
Technical Indicators
Market Signals| Indicator | CMP | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 41.71 |
| Support Level | $19.43 | $7.88 |
| Resistance Level | $20.59 | $9.10 |
| Average True Range (ATR) | 0.94 | 0.47 |
| MACD | 0.04 | -0.10 |
| Stochastic Oscillator | 60.39 | 16.16 |
Price Performance
Historical ComparisonAbout CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.